Login to Your Account

Avalon, GSK Deal: Start 10 New Firms via Mutual Cash Outlay

By Randy Osborne
Staff Writer

Wednesday, April 24, 2013
CHICAGO – A week after he talked with BioWorld Today about his success in helping pharmaceutical firms backfill their dwindling pipelines with promising, early stage deals, Avalon Ventures partner Jay Lichter disclosed a multi-company arrangement designed to do just that in a big way for GlaxoSmithKline plc.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription